JP2009544660A5 - - Google Patents

Download PDF

Info

Publication number
JP2009544660A5
JP2009544660A5 JP2009521246A JP2009521246A JP2009544660A5 JP 2009544660 A5 JP2009544660 A5 JP 2009544660A5 JP 2009521246 A JP2009521246 A JP 2009521246A JP 2009521246 A JP2009521246 A JP 2009521246A JP 2009544660 A5 JP2009544660 A5 JP 2009544660A5
Authority
JP
Japan
Prior art keywords
compound
formula
carbon atoms
equation
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009521246A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009544660A (ja
Filing date
Publication date
Priority claimed from EP06117779A external-priority patent/EP1882688A1/en
Application filed filed Critical
Publication of JP2009544660A publication Critical patent/JP2009544660A/ja
Publication of JP2009544660A5 publication Critical patent/JP2009544660A5/ja
Pending legal-status Critical Current

Links

JP2009521246A 2006-07-25 2007-07-24 合成プローブによる融合タンパク質の標識化 Pending JP2009544660A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06117779A EP1882688A1 (en) 2006-07-25 2006-07-25 Labelling of fusion proteins with synthetic probes
PCT/EP2007/057597 WO2008012296A1 (en) 2006-07-25 2007-07-24 Labelling of fusion proteins with synthetic probes

Publications (2)

Publication Number Publication Date
JP2009544660A JP2009544660A (ja) 2009-12-17
JP2009544660A5 true JP2009544660A5 (US07794700-20100914-C00152.png) 2010-06-24

Family

ID=36954295

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009521246A Pending JP2009544660A (ja) 2006-07-25 2007-07-24 合成プローブによる融合タンパク質の標識化

Country Status (5)

Country Link
US (2) US8227602B2 (US07794700-20100914-C00152.png)
EP (2) EP1882688A1 (US07794700-20100914-C00152.png)
JP (1) JP2009544660A (US07794700-20100914-C00152.png)
CN (1) CN101516857A (US07794700-20100914-C00152.png)
WO (1) WO2008012296A1 (US07794700-20100914-C00152.png)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005068616A2 (en) 2004-01-16 2005-07-28 Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. Immunokinases
AU2006264300B2 (en) 2005-07-06 2012-03-08 Vascular Pathways Inc. Intravenous catheter insertion device and method of use
EP1800695A1 (en) 2005-12-21 2007-06-27 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Immuno-RNA-constructs
ATE548972T1 (de) 2007-05-07 2012-03-15 Vascular Pathways Inc Intravenöse kathetereinführungs- und blutprobenvorrichtung
EP2171456A2 (en) * 2007-07-25 2010-04-07 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Self coupling recombinant antibody fusion proteins
WO2010031767A2 (en) * 2008-09-16 2010-03-25 Technische Universität München Fluorescent-labelled atpases
FR2936245B1 (fr) 2008-09-23 2012-07-06 Cis Bio Int Nouveaux substrats d'o6-alkylguanine-adn alkyltransferase et ses mutants.
US9872971B2 (en) 2010-05-14 2018-01-23 C. R. Bard, Inc. Guidewire extension system for a catheter placement device
US8932258B2 (en) 2010-05-14 2015-01-13 C. R. Bard, Inc. Catheter placement device and method
US9950139B2 (en) 2010-05-14 2018-04-24 C. R. Bard, Inc. Catheter placement device including guidewire and catheter control elements
US11925779B2 (en) 2010-05-14 2024-03-12 C. R. Bard, Inc. Catheter insertion device including top-mounted advancement components
US10384039B2 (en) 2010-05-14 2019-08-20 C. R. Bard, Inc. Catheter insertion device including top-mounted advancement components
US8690833B2 (en) 2011-01-31 2014-04-08 Vascular Pathways, Inc. Intravenous catheter and insertion device with reduced blood spatter
WO2012154277A1 (en) 2011-02-25 2012-11-15 C.R. Bard, Inc. Medical component insertion device including a retractable needle
USD903101S1 (en) 2011-05-13 2020-11-24 C. R. Bard, Inc. Catheter
JP6522339B2 (ja) 2011-11-21 2019-05-29 プロメガ コーポレイションPromega Corporation カルボキシxローダミン類似体
NO2788478T3 (US07794700-20100914-C00152.png) 2011-12-09 2018-01-20
US9267117B2 (en) 2012-03-15 2016-02-23 New England Biolabs, Inc. Mapping cytosine modifications
CN104203286B (zh) * 2012-03-21 2017-12-29 弗劳恩霍夫应用研究促进协会 用于光动力疗法的新型光免疫偶联物
CN108607150B (zh) 2013-01-30 2021-01-12 血管通路股份有限公司 用于静脉穿刺和导管放置的系统和方法
US9782568B2 (en) 2013-02-05 2017-10-10 Vascular Pathways, Inc. Systems and methods for needle and catheter advancement
EP2972229B1 (en) 2013-03-15 2017-12-27 Promega Corporation New silicon and germanium dyes for use in genetic identity
US9708658B2 (en) 2013-03-19 2017-07-18 New England Biolabs, Inc. Enrichment of target sequences
US10080787B2 (en) 2014-07-02 2018-09-25 New England Biolabs, Inc. Universal N-glycan binding reagent
WO2016037127A1 (en) 2014-09-05 2016-03-10 C.R. Bard, Inc. Catheter insertion device including retractable needle
JP2017537657A (ja) 2014-12-11 2017-12-21 ニユー・イングランド・バイオレイブス・インコーポレイテツド 標的配列の濃縮
USD903100S1 (en) 2015-05-01 2020-11-24 C. R. Bard, Inc. Catheter placement device
EP4029446A1 (en) 2015-05-15 2022-07-20 C.R. Bard, Inc. Needle assembly including a blood flash indicator
CN113444094B (zh) 2016-07-20 2023-12-22 纳莹(上海)生物科技有限公司 一种荧光探针及其制备方法和用途
CN109715093B (zh) 2016-09-12 2020-11-06 C·R·巴德股份有限公司 导管插入装置的血液控制
JP6953541B2 (ja) 2017-03-01 2021-10-27 シー・アール・バード・インコーポレーテッドC R Bard Incorporated カテーテル挿入装置
CN109574880B (zh) 2017-09-29 2022-06-17 纳莹(上海)生物科技有限公司 一种荧光探针及其制备方法和用途
WO2019173641A1 (en) 2018-03-07 2019-09-12 Bard Access Systems, Inc. Guidewire advancement and blood flashback systems for a medical device insertion system
CN110498799B (zh) 2018-05-18 2022-07-05 纳莹(上海)生物科技有限公司 一种荧光探针及其制备方法和用途
USD921884S1 (en) 2018-07-27 2021-06-08 Bard Access Systems, Inc. Catheter insertion device
CN111748089B (zh) * 2019-03-28 2023-07-18 成都先导药物开发股份有限公司 一种生物素标记化合物以及确定化合物结合靶标蛋白的方法
US11390915B2 (en) 2019-04-26 2022-07-19 New England Biolabs, Inc. Polynucleotide adapter design for reduced bias
EP4010057A4 (en) 2019-08-19 2023-10-18 Becton, Dickinson and Company CENTERLINE CATHETER PLACEMENT DEVICE
WO2021183921A1 (en) 2020-03-12 2021-09-16 New England Biolabs, Inc. A rapid diagnostic test for lamp
US11740240B2 (en) * 2020-07-20 2023-08-29 Bio-Rad Laboratories, Inc. Immunoassay for SARS-CoV-2 neutralizing antibodies and materials therefor
WO2022040443A2 (en) 2020-08-21 2022-02-24 New England Biolabs, Inc. A rapid diagnostic test for lamp
WO2023197015A1 (en) 2022-04-08 2023-10-12 New England Biolabs, Inc. Compositions and analysis of dephosphorylated oligoribonucleotides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19600934A1 (de) * 1996-01-12 1997-07-17 Basf Ag Substituierte Aza- und Diazacycloheptan- und Cyclooctanverbindungen und deren Verwendung
DE60041584D1 (de) * 1999-07-28 2009-04-02 Aventis Pharma Inc Substituierte oxoazaheterozyclische verbindungen
EP1546371A1 (en) * 2002-10-03 2005-06-29 Ecole Polytechnique Federale De Lausanne (Epfl) Substrates for o6-alkylguanine-dna alkyltransferase
WO2005085470A1 (en) * 2004-03-02 2005-09-15 Epfl Ecole Polytechnique Federale De Lausanne Specific substrates for o6- alkylguanine-dna alkyltransferase
US8178314B2 (en) * 2005-04-27 2012-05-15 Covalys Biosciences Ag Pyrimidines reacting with O6-alkylguanine-DNA alkyltransferase fusion protein and method for detecting protein

Similar Documents

Publication Publication Date Title
JP2009544660A5 (US07794700-20100914-C00152.png)
US11808768B2 (en) 1,1 ′-[[(substituted alkyl)imino]bis (alkylene)]bis- ferrocenes and their use in I electrochemical assays by labelling substrates of interest
JP2019514426A5 (US07794700-20100914-C00152.png)
Pirrung et al. High-Throughput Catch-and-Release Synthesis of Oxazoline Hydroxamates. Structure− Activity Relationships in Novel Inhibitors of Escherichia c oli LpxC: In Vitro Enzyme Inhibition and Antibacterial Properties
BRPI0516264A (pt) molécula de ácido nucleico, seqüência de nucleotìdeos, cassete de expressão, vetor de expressão, célula, métodos para expressar um anticorpo recombinante ou fragmento do mesmo, para melhorar a expressão de um anticorpo recombinante ou fragmento do mesmo, para produzir um anticorpo recombinante ou fragmento do mesmo e uma preparação de anticorpos e para detectar um produto irt em uma amostra, anticorpo e composição farmacêutica
SG179448A1 (en) Oxidation resistant indicator molecules
JP2015521616A5 (US07794700-20100914-C00152.png)
Pitié et al. Targeting the DNA Cleavage Activity of Copper Phenanthroline and Clip-Phen to A⊙ T Tracts via Linkage to a Poly-N-methylpyrrole
JP2010521485A5 (US07794700-20100914-C00152.png)
JP2013078329A5 (US07794700-20100914-C00152.png)
JP2016521250A5 (US07794700-20100914-C00152.png)
MA29416B1 (fr) Inhibiteurs d'age
JP2015511601A (ja) 広域抗生物質アリロマイシン類縁体
Shiyama et al. Design and synthesis of novel hydrophilic spacers for the reduction of nonspecific binding proteins on affinity resins
JP2004525888A (ja) オリゴまたはポリアルキレングリコール結合トロンビン阻害剤
Milner et al. Probing linker design in citric acid–ciprofloxacin conjugates
Caprioara et al. DNA‐based phosphane ligands
Bakka et al. Methyl propiolate and 3-butynone: Starting points for synthesis of amphiphilic 1, 2, 3-triazole peptidomimetics for antimicrobial evaluation
JP2011506296A5 (US07794700-20100914-C00152.png)
Adler et al. Enaminone‐based mimics of extended and hydrophilic α‐helices
JP2016505514A5 (US07794700-20100914-C00152.png)
Stadlbauer et al. Utilizing reversible copper (II) peptide coordination in a sequence‐selective luminescent receptor
JP2010030999A (ja) テロメラーゼ阻害剤
JP2011519884A5 (US07794700-20100914-C00152.png)
EP3878472A1 (en) Proteolysis targeting chimera (protac) for degradation of aurora a-kinase